Wed, Jan 15th, 2025 9:17 am
Leukemias are a relatively common set of blood cancers, with close to half a million cases diagnosed worldwide every year. An increase in the availability of diagnostic assays, and advances in leukemia treatments, have overall increased remission and survival time over the last several decades. Importantly, every diagnostic and follow-up test rely on the parallel usage of proper controls to assure cancer test results are accurate and precise.
Thu, Jun 6th, 2024 12:13 pm
Molecular diagnostics has emerged as a cornerstone for disease diagnosis, treatment guidance, and patient management. The ability of molecular assays to detect genetic alterations and identify specific pathogens plays a critical role in shaping and informing healthcare decisions. Therefore, the accuracy and reliability of these tests hinge upon a crucial, yet often underappreciated, aspect: quality control.
Tue, Apr 16th, 2024 6:33 pm
The College of American Pathologists (CAP) Accreditation Program Molecular Pathology Checklist (v. 08.24.2023) defines controls as “surrogates for patient specimens to monitor the ongoing performance of the entire analytic process in every run.”